These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 26398895)

  • 1. Connexin43 Inhibition Prevents Human Vein Grafts Intimal Hyperplasia.
    Longchamp A; Allagnat F; Alonso F; Kuppler C; Dubuis C; Ozaki CK; Mitchell JR; Berceli S; Corpataux JM; Déglise S; Haefliger JA
    PLoS One; 2015; 10(9):e0138847. PubMed ID: 26398895
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased connexin43 expression in human saphenous veins in culture is associated with intimal hyperplasia.
    Déglise S; Martin D; Probst H; Saucy F; Hayoz D; Waeber G; Nicod P; Ris HB; Corpataux JM; Haefliger JA
    J Vasc Surg; 2005 Jun; 41(6):1043-52. PubMed ID: 15944608
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hydrophilic statin suppresses vein graft intimal hyperplasia via endothelial cell-tropic Rho-kinase inhibition.
    Yamanouchi D; Banno H; Nakayama M; Sugimoto M; Fujita H; Kobayashi M; Kuwano H; Komori K
    J Vasc Surg; 2005 Oct; 42(4):757-64. PubMed ID: 16242565
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of phosphatidylinositol 3-kinase signaling reduces intimal hyperplasia in aortocoronary saphenous vein grafts.
    Hata JA; Petrofski JA; Schroder JN; Williams ML; Timberlake SH; Pippen A; Corwin MT; Solan AK; Jakoi A; Gehrig TR; Kontos CD; Milano CA
    J Thorac Cardiovasc Surg; 2005 Jun; 129(6):1405-13. PubMed ID: 15942585
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Postprocedure administration of insulin in canine autologous vein grafting: a potential strategy to attenuate intimal hyperplasia.
    Zhou N; Yu QJ; Si R; Gao HK; Wang T; Gao F; Wang HC; Bian JF
    J Cardiovasc Pharmacol; 2010 Oct; 56(4):402-12. PubMed ID: 20625311
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pioglitazone prevents intimal hyperplasia in experimental rabbit vein grafts.
    Morisaki K; Shibata R; Takahashi N; Ouchi N; Maehara Y; Murohara T; Komori K
    J Vasc Surg; 2011 Dec; 54(6):1753-9. PubMed ID: 21890304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene delivery to aortocoronary saphenous vein grafts in a large animal model of intimal hyperplasia.
    Petrofski JA; Hata JA; Gehrig TR; Hanish SI; Williams ML; Thompson RB; Parsa CJ; Koch WJ; Milano CA
    J Thorac Cardiovasc Surg; 2004 Jan; 127(1):27-33. PubMed ID: 14752409
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lazaroid therapy (methylaminochroman: U83836E) reduces vein graft intimal hyperplasia.
    Davies MG; Dalen H; Barber L; Svendsen E; Hagen PO
    J Surg Res; 1996 Jun; 63(1):128-36. PubMed ID: 8661185
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Gbetagamma inhibitor reduces intimal hyperplasia in aortocoronary saphenous vein grafts.
    Petrofski JA; Hata JA; Williams ML; Parsa CJ; Thompson RB; Hanish SI; Gehrig TR; Koch WJ; Milano CA
    J Thorac Cardiovasc Surg; 2005 Dec; 130(6):1683-90. PubMed ID: 16308016
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclic adenosine monophosphate response-element binding protein activation by mitogen-activated protein kinase-activated protein kinase 3 and four-and-a-half LIM domains 5 plays a key role for vein graft intimal hyperplasia.
    Nakanishi K; Saito Y; Azuma N; Sasajima T
    J Vasc Surg; 2013 Jan; 57(1):182-93, 193.e1-10. PubMed ID: 23127979
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MK2 inhibitory peptide delivered in nanopolyplexes prevents vascular graft intimal hyperplasia.
    Evans BC; Hocking KM; Osgood MJ; Voskresensky I; Dmowska J; Kilchrist KV; Brophy CM; Duvall CL
    Sci Transl Med; 2015 Jun; 7(291):291ra95. PubMed ID: 26062847
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibitory effects of NFkappaB decoy oligodeoxynucleotides on neointimal hyperplasia in a rabbit vein graft model.
    Miyake T; Aoki M; Shiraya S; Tanemoto K; Ogihara T; Kaneda Y; Morishita R
    J Mol Cell Cardiol; 2006 Sep; 41(3):431-40. PubMed ID: 16762361
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of Girdin in intimal hyperplasia in vein grafts and efficacy of atelocollagen-mediated application of small interfering RNA for vein graft failure.
    Miyachi H; Mii S; Enomoto A; Murakumo Y; Kato T; Asai N; Komori K; Takahashi M
    J Vasc Surg; 2014 Aug; 60(2):479-489.e5. PubMed ID: 23948670
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Photochemical Tissue Passivation Reduces Vein Graft Intimal Hyperplasia in a Swine Model of Arteriovenous Bypass Grafting.
    Goldstone RN; McCormack MC; Khan SI; Salinas HM; Meppelink A; Randolph MA; Watkins MT; Redmond RW; Austen WG
    J Am Heart Assoc; 2016 Jul; 5(8):. PubMed ID: 27464790
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early growth response gene-1 decoy oligonucleotides inhibit vascular smooth muscle cell proliferation and neointimal hyperplasia of autogenous vein graft in rabbits.
    Wang X; Mei Y; Ji Q; Feng J; Cai J; Xie S
    Interact Cardiovasc Thorac Surg; 2015 Jul; 21(1):50-4. PubMed ID: 25820759
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduction of vein graft intimal hyperplasia by ex vivo treatment with desferrioxamine manganese.
    Hagen PO; Davies MG; Schuman RW; Murray JJ
    J Vasc Res; 1992; 29(6):405-9. PubMed ID: 1489885
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Topical mitogen-activated protein kinases inhibition reduces intimal hyperplasia in arterialized vein grafts.
    Gulkarov I; Bohmann K; Cinnante KM; Pirelli L; Yu PJ; Grau JB; Pintucci G; Galloway AC; Mignatti P
    J Surg Res; 2009 Jun; 154(1):150-6. PubMed ID: 18805551
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ezetimibe reduces intimal hyperplasia in rabbit jugular vein graft.
    Maekawa T; Komori K; Morisaki K; Itoh T
    J Vasc Surg; 2012 Dec; 56(6):1689-97. PubMed ID: 22857809
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting connexin 43 prevents platelet-derived growth factor-BB-induced phenotypic change in porcine coronary artery smooth muscle cells.
    Chadjichristos CE; Morel S; Derouette JP; Sutter E; Roth I; Brisset AC; Bochaton-Piallat ML; Kwak BR
    Circ Res; 2008 Mar; 102(6):653-60. PubMed ID: 18239136
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of RNA interference targeting mammalian target of rapamycin on the proliferation of vascular smooth muscle cell and the intimal hyperplasia].
    Hu XH; Zhang Q; Yang J; Liu CW; Zhang ZS; Yang DH
    Zhonghua Yi Xue Za Zhi; 2007 Jan; 87(1):58-62. PubMed ID: 17403315
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.